Positive Results From Chronic Study With Bayer's Rivaroxaban Will Be Presented As A Late Breaker At ASH 2009
Links shared publicly online about this topic.
- 1,586total visits
Positive Results From Chronic Study With Bayer's Rivaroxaban Will Be Presented As A Late Breaker At ASH 2009
Findings from the phase iii einstein-extension study will be presented in the late breaking abstract session on december 8, 2009, (7:30 am est, hall f, ernest n. morial convention center) at the 5
View full resource at medicalnewstoday.com
Tags: Anti-Clotting Medication, Xarelto, Bayer
Most Recently Shared on November 21, 2009 at 3:25 pm By:
Positive Results From Chronic Study With Bayer's Rivaroxaban Will Be Presented As A Late Breaker At ASH 2009 http://ow.ly/163nz6
Also Shared By:
Advertisement
MNT Cardiovascular
@mnt_cardiovasc
Positive Results From Chronic Study With Bayer's Rivaroxaban Will Be Presented As A Late Breaker At ASH 2009: F.. http://bit.ly/5wpLCD
1 year ago...